{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2008-N-0474\" sorted by posted_date descending", "rows": [["FDA-2008-N-0474-0038", "FDA", "FDA-2008-N-0474", "L'Oreal Response Letter from October 2015 Submission", "Other", "Answer", "2016-06-27T04:00:00Z", 2016, 6, "2016-06-27T04:00:00Z", null, "2016-06-27T18:31:56Z", null, 0, 0, "0900006482071493"], ["FDA-2008-N-0474-0037", "FDA", "FDA-2008-N-0474", "Letter from FDA CDER to L'Oreal USA Products, Inc.", "Other", "Letter(s)", "2015-12-14T05:00:00Z", 2015, 12, "2015-12-14T05:00:00Z", null, "2015-12-14T20:53:46Z", null, 0, 0, "0900006481da43dc"], ["FDA-2008-N-0474-0036", "FDA", "FDA-2008-N-0474", "Letter from L'Oreal USA Products Inc. to FDA CDER", "Other", "Letter(s)", "2015-10-13T04:00:00Z", 2015, 10, "2015-10-13T04:00:00Z", null, "2015-10-13T13:22:00Z", null, 0, 0, "0900006481cc3e87"], ["FDA-2008-N-0474-0035", "FDA", "FDA-2008-N-0474", "Advice Letter from FDA CDER to L'Oreal USA Products Inc", "Other", "Letter(s)", "2015-09-02T04:00:00Z", 2015, 9, "2015-09-02T04:00:00Z", null, "2015-09-02T15:26:52Z", null, 0, 0, "0900006481c50275"], ["FDA-2008-N-0474-0034", "FDA", "FDA-2008-N-0474", "Response to FDA Meeting Minutes May 11. 2015 from L'Oreal USA", "Other", "Minutes", "2015-07-21T04:00:00Z", 2015, 7, "2015-07-21T04:00:00Z", null, "2015-07-21T15:05:49Z", null, 0, 0, "0900006481b954ba"], ["FDA-2008-N-0474-0033", "FDA", "FDA-2008-N-0474", "Memorandum of Meeting Minutes May 11, 2015 between FDA CDER and L'Oreal USA Products Inc.", "Other", "Memorandum", "2015-06-12T04:00:00Z", 2015, 6, "2015-06-12T04:00:00Z", null, "2015-06-12T14:51:44Z", null, 0, 0, "0900006481b30d22"], ["FDA-2008-N-0474-0029", "FDA", "FDA-2008-N-0474", "Request for a Meeting from L'Oreal USA Products, Inc to FDA CDER", "Other", "Request", "2015-05-01T04:00:00Z", 2015, 5, "2015-05-01T04:00:00Z", null, "2015-05-01T14:31:21Z", null, 0, 0, "0900006481a6df2d"], ["FDA-2008-N-0474-0032", "FDA", "FDA-2008-N-0474", "Response from FDA CDER to L'Oreal USA Products Inc", "Other", "Response(s)", "2015-05-01T04:00:00Z", 2015, 5, "2015-05-01T04:00:00Z", null, "2015-05-01T16:54:55Z", null, 0, 0, "0900006481ac7a72"], ["FDA-2008-N-0474-0024", "FDA", "FDA-2008-N-0474", "Reference 6 - International Conference on Harmonization (ICH), Guidance for Industry, The Need for Long-Term Rodent Carcinogenicity Studies of Pharmaceuticals S1A, March 1996", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:00:53Z", null, 0, 0, "0900006481a113a5"], ["FDA-2008-N-0474-0019", "FDA", "FDA-2008-N-0474", "Reference 1 - FDA, Guidance for Industry, Photosafety Testing, May 2003", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T15:59:35Z", null, 0, 0, "0900006481a113a0"], ["FDA-2008-N-0474-0028", "FDA", "FDA-2008-N-0474", "Reference 10 - International Conference on Harmonization (ICH) Guideline for Industry, Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies S3A, March 1995", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:01:35Z", null, 0, 0, "0900006481a113b5"], ["FDA-2008-N-0474-0022", "FDA", "FDA-2008-N-0474", "Reference 4 - Schmidt et al, Photoallergic Contact Dermatitis Due to Combined UVB (4-Methylbenzylidene Camphor/Octyl Methoxycinnamate) and UVA (Benzophenone-3/Butyl Methoxydibenzoylmethane) Absorber Sensitization", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:00:22Z", null, 0, 0, "0900006481a113a3"], ["FDA-2008-N-0474-0018", "FDA", "FDA-2008-N-0474", "Over-the-Counter Sunscreen Drug Products\u2014Regulatory Status of\nEcamsule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2015-02-25T05:00:00Z", 2015, 2, "2015-02-25T05:00:00Z", "2015-04-14T03:59:59Z", "2015-05-02T02:02:23Z", "2015-03883", 0, 0, "0900006481a16312"], ["FDA-2008-N-0474-0020", "FDA", "FDA-2008-N-0474", "Reference 2 - Leonard et al, The New Standard Battery of Photopatch Test in France.", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:00:03Z", null, 0, 0, "0900006481a113a1"], ["FDA-2008-N-0474-0027", "FDA", "FDA-2008-N-0474", "Reference 9 - International Conference on Harmonization (ICH)  Harmonized Tripartite Guideline for Industry Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S5(R2), 2005", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:01:25Z", null, 0, 0, "0900006481a113b4"], ["FDA-2008-N-0474-0021", "FDA", "FDA-2008-N-0474", "Reference 3 - Schauder et al, Contact and Photocontact Sensitivity to Sunscreens. Review of a 15-Year Experience and of the Literature", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:00:12Z", null, 0, 0, "0900006481a113a2"], ["FDA-2008-N-0474-0023", "FDA", "FDA-2008-N-0474", "Reference 5 - FDA Guidance for Industry, Guideline for the Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application, February 1987", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:00:39Z", null, 0, 0, "0900006481a113a4"], ["FDA-2008-N-0474-0026", "FDA", "FDA-2008-N-0474", "Reference 8 - International Conference on Harmonization (ICH) Guidance for Industry - S1C(R2) Dose Selection for Carcinogenicity Studies (Revision 1), September 2008", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:01:16Z", null, 0, 0, "0900006481a113a7"], ["FDA-2008-N-0474-0025", "FDA", "FDA-2008-N-0474", "Reference 7 - International Conference on Harmonization (ICH) Guidance for Industry, S1B Testing for Carcinogenicity of Pharmaceuticals, July 1997", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T16:01:04Z", null, 0, 0, "0900006481a113a6"], ["FDA-2008-N-0474-0015", "FDA", "FDA-2008-N-0474", "Volume 9 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T14:35:33Z", null, 0, 0, "0900006481a093e5"], ["FDA-2008-N-0474-0010", "FDA", "FDA-2008-N-0474", "Volume 4 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:43:58Z", null, 0, 0, "0900006481a093e0"], ["FDA-2008-N-0474-0016", "FDA", "FDA-2008-N-0474", "Volume 10 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T14:39:32Z", null, 0, 0, "0900006481a09458"], ["FDA-2008-N-0474-0009", "FDA", "FDA-2008-N-0474", "Volume 3 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:43:51Z", null, 0, 0, "0900006481a093df"], ["FDA-2008-N-0474-0008", "FDA", "FDA-2008-N-0474", "Volume 2 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:43:42Z", null, 0, 0, "0900006481a093de"], ["FDA-2008-N-0474-0013", "FDA", "FDA-2008-N-0474", "Volume 7 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T14:07:52Z", null, 0, 0, "0900006481a093e3"], ["FDA-2008-N-0474-0012", "FDA", "FDA-2008-N-0474", "Volume 6 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:57:17Z", null, 0, 0, "0900006481a093e2"], ["FDA-2008-N-0474-0011", "FDA", "FDA-2008-N-0474", "Volume 5 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:49:38Z", null, 0, 0, "0900006481a093e1"], ["FDA-2008-N-0474-0017", "FDA", "FDA-2008-N-0474", "Volume 11 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T15:10:39Z", null, 0, 0, "0900006481a09459"], ["FDA-2008-N-0474-0014", "FDA", "FDA-2008-N-0474", "Volume 8 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T14:15:05Z", null, 0, 0, "0900006481a093e4"], ["FDA-2008-N-0474-0007", "FDA", "FDA-2008-N-0474", "Volume 1 Time and Extent Application (TEA) Part 2 from L'Oreal USA Products, Inc., re Data and Information for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated November 18, 2008, FDA-2008-N-0474-0006", "Supporting & Related Material", "Background Material", "2015-02-19T05:00:00Z", 2015, 2, null, null, "2015-02-19T13:17:08Z", null, 0, 0, "0900006481a093dd"], ["FDA-2008-N-0474-0003", "FDA", "FDA-2008-N-0474", "Time and Extent Application (TEA) from  L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated September 18, 2007, Background Material Book 2", "Supporting & Related Material", "Background Material", "2008-09-15T04:00:00Z", 2008, 9, null, null, "2015-02-18T19:45:14Z", null, 0, 0, "090000648070674b"], ["FDA-2008-N-0474-0002", "FDA", "FDA-2008-N-0474", "Time and Extent Application (TEA) from L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated September 18, 2007, Background Material Book 1", "Supporting & Related Material", "Background Material", "2008-09-15T04:00:00Z", 2008, 9, null, null, "2015-02-18T19:42:31Z", null, 0, 0, "0900006480706718"], ["FDA-2008-N-0474-0005", "FDA", "FDA-2008-N-0474", "Report/Review of Time and Extent Application (TEA) from FDA CDER for L'Oreal USA Products, Inc., TEA (Terephthalylidene Dicamphor Sufonic Acid) dated September 25, 2007", "Supporting & Related Material", "Report", "2008-09-15T04:00:00Z", 2008, 9, null, null, "2015-02-18T19:48:57Z", null, 0, 0, "09000064807067a2"], ["FDA-2008-N-0474-0004", "FDA", "FDA-2008-N-0474", "Time and Extent Application (TEA) Amendment from  L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated February 5, 2008", "Supporting & Related Material", "Background Material", "2008-09-15T04:00:00Z", 2008, 9, null, null, "2015-02-18T19:46:06Z", null, 0, 0, "0900006480706777"], ["FDA-2008-N-0474-0001", "FDA", "FDA-2008-N-0474", "Ecamsule Eligibility for Inclusion in Monograph; Over-the-Counter Sunscreen Drug Products for Human Use; Request for Safety and Effectiveness Data", "Notice", "Requests for Information (RFI)", "2008-09-12T04:00:00Z", 2008, 9, "2008-09-12T04:00:00Z", "2008-12-12T04:59:59Z", "2015-02-20T03:01:32Z", "E8-21291", 0, 0, "09000064807017ef"]], "truncated": false, "filtered_table_rows_count": 35, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2008-N-0474"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474", "results": [{"value": "FDA", "label": "FDA", "count": 35, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2008-N-0474", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474", "results": [{"value": 2015, "label": 2015, "count": 29, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&posted_year=2015", "selected": false}, {"value": 2008, "label": 2008, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&posted_year=2008", "selected": false}, {"value": 2016, "label": 2016, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&posted_year=2016", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0474&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 813.0206689238548, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}